Client updates /  Israel Competition Authority

The Israel Competition Authority (ICA) published a draft consent decree with Bristol-Myers Squibb and Neopharm, requiring payments of over ILS 44 million by the companies and ILS 200,000 by a Neopharm executive, following indications of monopolistic abuse.

The Israel Competition Authority (ICA) conducted a thorough investigation of the S. Schestowitz Group, an Israeli company in the food and consumer goods sector, due to suspicions the company operated a cartel in the food industry in violation of the Economic Competition Law and the Law for the Promotion of Competition in the Food and Pharmacy Industries.

The Israel Competition Authority (ICA) announced that as of March 31, 2025, it will begin publishing on its website a list of pending merger transactions and exemption applications for restrictive trade arrangements that are under its review.

On December 30, 2020, the Israel Competition Authority (ICA) notified SOS, a company in the field of fueling services, it was imposing a financial sanction of NIS 6.3 million on the company. In addition, it imposed a financial sanction of NIS 350,000 on an executive officer in the company. Following a complaint an SOS competitor filed with the ICA, the ICA concluded SOS had entered into exclusivity agreements with its clients. The company also implemented a policy whereby it would not provide fueling services to a client if the client simultaneously engaged with a competing fuel service provider.